XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 595,049 $ 746,724
Trade accounts receivable, less allowance for doubtful accounts (2021 – $2,574; 2020 – $2,083) 520,746 530,838
Other accounts receivable 56,298 61,958
Inventories 745,598 750,237
Other current assets 160,415 116,427
Total current assets 2,078,106 2,206,184
Property, plant and equipment, at cost 7,783,962 7,427,641
Less accumulated depreciation and amortization 2,128,485 2,073,016
Net property, plant and equipment 5,655,477 5,354,625
Investments 902,504 656,244
Other assets 251,786 219,268
Goodwill 1,623,471 1,665,520
Other intangibles, net of amortization 320,981 349,105
Total assets 10,832,325 10,450,946
Current liabilities:    
Accounts payable 545,922 483,221
Accrued expenses 956,506 440,763
Current portion of long-term debt 611 804,677
Dividends payable 45,450 40,937
Income taxes payable 42,553 32,251
Total current liabilities 1,591,042 1,801,849
Long-term debt 2,021,487 2,767,381
Postretirement benefits 47,020 48,075
Pension benefits 299,875 340,818
Other noncurrent liabilities 617,488 629,377
Deferred income taxes 360,181 394,852
Commitments and contingencies (Note 10)
Albemarle Corporation shareholders’ equity:    
Common stock, $.01 par value, issued and outstanding – 116,976 in 2021 and 106,842 in 2020 1,170 1,069
Additional paid-in capital 2,913,383 1,438,038
Accumulated other comprehensive loss (366,436) (326,132)
Retained earnings 3,145,999 3,155,252
Total Albemarle Corporation shareholders’ equity 5,694,116 4,268,227
Noncontrolling interests 201,116 200,367
Total equity 5,895,232 4,468,594
Total liabilities and equity $ 10,832,325 $ 10,450,946